These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36769125)

  • 21. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chrysin Inhibits Proinflammatory Factor-Induced EMT Phenotype and Cancer Stem Cell-Like Features in HeLa Cells by Blocking the NF-κB/Twist Axis.
    Dong W; Chen A; Chao X; Li X; Cui Y; Xu C; Cao J; Ning Y
    Cell Physiol Biochem; 2019; 52(5):1236-1250. PubMed ID: 31001962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells.
    Luo J; Zhou H; Wang F; Xia X; Sun Q; Wang R; Cheng B
    Int J Oncol; 2013 May; 42(5):1636-43. PubMed ID: 23450368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of GPR50 promotes the proliferation, migration and autophagy of hepatocellular carcinoma cells in vitro.
    Zhao W; Xi L; Yu G; Wang G; Chang C
    J Cell Commun Signal; 2023 Dec; 17(4):1435-1447. PubMed ID: 37378811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway.
    Pan H; Zhou W; He W; Liu X; Ding Q; Ling L; Zha X; Wang S
    Int J Mol Med; 2012 Aug; 30(2):337-43. PubMed ID: 22580499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HER2 regulates cancer stem-like cell phenotype in ALK translocated NSCLC.
    Honkanen T; Wilenius E; Koivunen P; Koivunen JP
    Int J Oncol; 2017 Aug; 51(2):599-606. PubMed ID: 28656214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer.
    Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez LE; Gaytan-Cervantes J; Muñoz-Galindo L; Piña-Sanchez P; Martinez-Ruiz G; Torres J; Garcia-Lopez P; Gonzalez-Torres C; Ruiz V; Avila-Moreno F; Velasco-Velazquez M; Perez-Tapia M; Maldonado V
    Sci Rep; 2016 Nov; 6():37340. PubMed ID: 27876836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
    Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
    Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPR50 interacts with neuronal NOGO-A and affects neurite outgrowth.
    Grünewald E; Kinnell HL; Porteous DJ; Thomson PA
    Mol Cell Neurosci; 2009 Dec; 42(4):363-71. PubMed ID: 19699797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer.
    Crone SG; Jacobsen A; Federspiel B; Bardram L; Krogh A; Lund AH; Friis-Hansen L
    Mol Cancer; 2012 Sep; 11():71. PubMed ID: 22992343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization.
    Levoye A; Dam J; Ayoub MA; Guillaume JL; Couturier C; Delagrange P; Jockers R
    EMBO J; 2006 Jul; 25(13):3012-23. PubMed ID: 16778767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orphan receptor GPR50 attenuates inflammation and insulin signaling in 3T3-L1 preadipocytes.
    Yao Z; Meng J; Long J; Li L; Qiu W; Li C; Zhang JV; Ren PG
    FEBS Open Bio; 2023 Jan; 13(1):89-101. PubMed ID: 36333974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-κB activity.
    Hsu RM; Zhong CY; Wang CL; Liao WC; Yang C; Lin SY; Lin JW; Cheng HY; Li PY; Yu CJ
    Cell Commun Signal; 2018 Apr; 16(1):19. PubMed ID: 29703230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells.
    Qin B; Cheng K
    Breast Cancer Res; 2010; 12(5):R74. PubMed ID: 20863366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
    Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
    Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPR50-Ctail cleavage and nuclear translocation: a new signal transduction mode for G protein-coupled receptors.
    Ahmad R; Lahuna O; Sidibe A; Daulat A; Zhang Q; Luka M; Guillaume JL; Gallet S; Guillonneau F; Hamroune J; Polo S; Prévot V; Delagrange P; Dam J; Jockers R
    Cell Mol Life Sci; 2020 Dec; 77(24):5189-5205. PubMed ID: 31900622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroanatomical distribution of the orphan GPR50 receptor in adult sheep and rodent brains.
    Batailler M; Mullier A; Sidibe A; Delagrange P; Prévot V; Jockers R; Migaud M
    J Neuroendocrinol; 2012 May; 24(5):798-808. PubMed ID: 22512326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways.
    Ni SJ; Zhao LQ; Wang XF; Wu ZH; Hua RX; Wan CH; Zhang JY; Zhang XW; Huang MZ; Gan L; Sun HL; Dimri GP; Guo WJ
    J Hematol Oncol; 2018 Feb; 11(1):17. PubMed ID: 29422082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-
    Sun X; Chang X; Wang Y; Xu B; Cao X
    Biomed Res Int; 2019; 2019():9241769. PubMed ID: 31341911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.